"10.1371_journal.pone.0145228","plos one","2015-12-15T00:00:00Z","William P Halford; Joshua Geltz; Ronald J Messer; Kim J Hasenkrug","Dept of Microbiology and Immunology, Southern Illinois University School of Medicine, Springfield, IL, 62702, United States of America; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, United States of America","Conceived and designed the experiments: WPH KJH. Performed the experiments: WPH RJM JG. Analyzed the data: WPH RJM JG. Contributed reagents/materials/analysis tools: WPH KJH RJM JG. Wrote the paper: WPH KJH.","The authors of this manuscript have read the journals policy and have the following competing interests. William Halford is a co-author on United States Patent Number 8,802,109, which describes the uses of herpes simplex virus mutant ICP0 in the design of a live-attenuated HSV-2 vaccine strain. In addition, William Halford is a co-founder of Rational Vaccines Incorporated which has licensed U.S. Patents 7,785,605 and 8,802,109. This does not alter the authorsâ€™ adherence to all PLOS ONE policies on sharing data and materials.","2015","12","William P Halford","WPH",4,TRUE,2,3,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
